Zhang et al. determined that increased BRCA1 expression in epithelial ovarian cancer tumor tissues is associated with resistance to platinum-based drugs, supporting the evidence that loss of BRCA1 function may contribute to the reversal of resistance [154]. The gene discussed is BRCA1; the disease is neoplasm.